DUCTAL ECTASIA IN SYNDROMIC CONTEXTS: A COMPARATIVE META-ANALYSIS OF CLINICAL FEATURES IN NEUROFIBROMATOSIS TYPE 1, COWDEN SYNDROME, AND PEUTZ-JEGHERS SYNDROME

Main Article Content

Dr Hashim Mahmood
Dr Usama Zahid Raja
Alian Fatima
Dr Urfa Mahmood
Dr Basma Jawed
Dr Wahaj Naeem
Dana Al Tarawneh
Dr Ashtar Kariem
Dr Nimra Riaz

Keywords

.

Abstract

Background: Ductal ectasia is frequently observed in various syndromic contexts, including Neurofibromatosis Type 1 (NF1), Cowden Syndrome, and Peutz-Jeghers Syndrome. The clinical features of ductal ectasia can vary significantly among these syndromes.


 Objective: To compare the clinical features of ductal ectasia in patients with NF1, Cowden Syndrome, and Peutz-Jeghers Syndrome through a systematic review and meta-analysis.


 Methods: A comprehensive literature search was conducted in PubMed, EMBASE, and Cochrane Library databases. Studies were selected based on predefined inclusion criteria, focusing on patients diagnosed with ductal ectasia in the context of NF1, Cowden Syndrome, and Peutz-Jeghers Syndrome. Data were extracted and analyzed for prevalence, clinical presentation, and complications.


Results: The analysis included 20 studies, encompassing 1,200 patients. Significant differences were observed in the prevalence, clinical presentation, and complications of ductal ectasia among the three syndromes.


 Conclusion: Ductal ectasia presents with distinct clinical features in NF1, Cowden Syndrome, and Peutz-Jeghers Syndrome, underscoring the need for tailored diagnostic and management approaches

Abstract 128 | PDF Downloads 48

References

1. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with Neurofibromatosis 1. J Med Genet. 2007;44(2):81-88.
2. Uusitalo E, Leppävirta J, Koffert A, et al. Incidence and mortality of Neurofibromatosis: A total population study in Finland. J Invest Dermatol. 2015;135(3):904-906.
3. McClatchey AI. Neurofibromatosis. Annu Rev Pathol. 2007;2:191-216.
4. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden Syndrome and the • PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. J Natl Cancer Inst. 2013;105(21):1607-1616.
5. Nelen MR, Kremer H, Konings IB, et al. Novel PTEN mutations in patients with Cowden disease: Absence of clear genotype-phenotype correlations. Eur J Hum Genet. 1999;7(3):267-273.
6. Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16(11):1289-1300.
7. Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med. 2009;11(10):687-694
8. Hearle N, Schumacher V, Menko FH, et al. Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome. Clin Cancer Res. 2006;12(10):3209-3215.
9. Amos CI, Zhu D, Carlson M, et al. Clinical and Molecular Features of the Peutz-Jeghers Syndrome. N Engl J Med. 2004;351(18):1831-1833.
10. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol. 2006;4(4):408-415.
11. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009;123(1):124-133
12. Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene. 2008;27(41):5387-5397.
13. Lachlan KL, Lucassen AM, Bunyan DJ, Temple IK. Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome represent one condition with variable expression and/or age-related penetrance: five new cases and a review of previously reported cases. J Med Genet. 2007;44(9):579-584.
14. Chen LM, Yadav DV, Bird LM, et al. Functional analysis of PTEN mutations in the context of Cowden syndrome: Biochemical, structural, and clinical insights. Hum Mutat. 2007;28(6):579-593.
15. Lachlan KL, Lucassen AM, Bunyan DJ, Temple IK. Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome represent one condition with variable expression and/or age-related penetrance: five new cases and a review of previously reported cases. J Med Genet. 2007;44(9):579-584.

Most read articles by the same author(s)